Jason Owen-Smith

Michigan Institute for Clinical and Health Research (MICHR) - U-award

Research Project Description
George A. Mashour, Catherine A. Spino, Daniel J. Clauw, Teri Ann Grieb, David Alan Hanauer, Sachin Kheterpal, Susan D. Goold, Michael S. Klinkman, Donald Ray Vereen, Susan Jennifer Woolford, Barbara Anne Israel, Vicki Lynn Ellingrod, Donna S. Shewach, Susan Lynn Murphy, Claire Z. Kalpakjian, Karen Bell Farris, Melvin G. McInnis, Kelley Kidwell, Michael E. Geisser, Raymond J. Hutchinson, Alan Tait, Julie C. Lumeng, Neil Burton Alexander, Raymond Yung, Lona Mody, David A. Williams, Alexander Tsodikov, Anna Suk-Fong Lok, Nicholas W. Lukacs, Charles P. Friedman, Cleopatra Howard Caldwell, Steve L. Kunkel, Jason Owen-Smith, Felichism W. Kabo, Constance Chang, Kevin Ralph Ward, Eric S. White, Seth A. Warschausky, Mousumi Banerjee, Emily Catherine Somers, Gary D. Hammer, Kayte Spector-Bagdady, Erica Elizabeth Marsh

The Michigan Institute for Clinical & Health Research (MICHR) is a catalytic hub that significantly impacts the translation of investigative science into innovative improvements in clinical care and health policy. Our objective is to empower researchers and research communities within and outside the University of Michigan (U-M), creating a positive impact on health across local, regional, national, and global scales. We will achieve this objective through the following overarching specific aims: 1) Innovate and implement effective educational approaches to develop a skilled and diverse translational research workforce; 2) Catalyze effective research with community partnerships to accelerate the translation of breakthroughs that benefit society; 3) Strengthen research across the translational spectrum and the lifespan; 4) Advance the science of translational research through experimental innovations that we hypothesize will enable higher quality and more efficient research methods and processes 5) Develop, demonstrate, and disseminate enabling technologies that facilitate the translation of biomedical discoveries to health impact. MICHR aspires to have a unique, substantial, measurable, and recognizable impact on U-M and the health of our communities. In order to achieve this with efficiency, we have critically evaluated pre-existing strengths and emerging opportunities across the institutional research landscape. MICHR will enhance and develop partnerships with major research and regulatory units on campus to develop an efficient pipeline that accelerates the translation and implementation of discoveries while also promoting cross-cutting signature initiatives that engage research and community members from all phases of translation.

National Center for Advancing Translational Sciences
(1 UL1 TR 002240 01)

Funding Period: 6/1/2017 to 2/28/2022

PSC In The News

RSS Feed icon

Shaefer comments on the Cares Act impact in negating hardship during COVID-19 pandemic

Heller comments on lasting safety benefit of youth employment programs

More News


Dean Yang's Combatting COVID-19 in Mozambique study releases Round 1 summary report

Help Establish Standard Data Collection Protocols for COVID-19 Research

More Highlights

Connect with PSC follow PSC on Twitter Like PSC on Facebook